
Sign up to save your podcasts
Or


In this episode, we speak with Associate Professor Leszek Lisowski, Head of the Translational Vectorology Unit at the Children's Medical Research Institute (CMRI), about the cutting-edge world of gene therapy. He explains how viral vectors are engineered to deliver life-saving treatments for rare genetic diseases - many of which are so uncommon, they're only known by the name of the affected gene. Despite being often overlooked, genetic diseases impact 10% of adults and 30% of children in hospitals. Leszek sheds light on the challenges of diagnosis, the promise of emerging genetic testing, and how his work is paving the way for more accurate, effective therapies.
Linkedin: Children's Medical Research Institute, Leszek Lisowski
Facebook: @jeansforgenes
Instagram: @jeansforgenesau
By Dr Karl Kruszelnicki4.2
3636 ratings
In this episode, we speak with Associate Professor Leszek Lisowski, Head of the Translational Vectorology Unit at the Children's Medical Research Institute (CMRI), about the cutting-edge world of gene therapy. He explains how viral vectors are engineered to deliver life-saving treatments for rare genetic diseases - many of which are so uncommon, they're only known by the name of the affected gene. Despite being often overlooked, genetic diseases impact 10% of adults and 30% of children in hospitals. Leszek sheds light on the challenges of diagnosis, the promise of emerging genetic testing, and how his work is paving the way for more accurate, effective therapies.
Linkedin: Children's Medical Research Institute, Leszek Lisowski
Facebook: @jeansforgenes
Instagram: @jeansforgenesau

108 Listeners

125 Listeners

55 Listeners

30 Listeners

868 Listeners

194 Listeners

777 Listeners

133 Listeners

67 Listeners

314 Listeners

42 Listeners

248 Listeners

44 Listeners

8 Listeners

110 Listeners